
Decan Pharma Private Limited
About Decan Pharma Private Limited
Data last updated:
Decan Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the other human health activities segment of the healthcare sector. It was incorporated on 05 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U85190MP2021PTC054382. Its GSTIN is 23AAICD2341L1ZS (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Hari Shankar Rajawat and Deependra Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at C/O Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006.
As per the financials filed for FY 2023, the company reported a revenue of ₹3 Lakh, a decline of 85% compared to the previous year. For the same year it recorded a net loss of ₹61,417 (net margin -20.5%) and EBITDA of -₹61,417 (EBITDA margin -20.5%).
Company details
Contact details
Decan Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006
- IndustryHealthcare, Other Human Health Activities, Human Health Activities
To see the full contact details of Decan Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Decan Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Decan Pharma Private Limited, buy the company report.
Financials of Decan Pharma Private Limited
FY 2023 filings availableDecan Pharma Private Limited reported revenue of ₹3 Lakh (down 85% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 85% in the latest year. EBITDA fell 308% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹61,417 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹61,417 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -20.5% | ||
| Net Profit Margin | -20.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Decan Pharma Private Limited, buy the company report.
Board of directors of Decan Pharma Private Limited
Decan Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Hari Shankar Rajawat | Director | 27 Feb 2021 | 5 Years 8 Months | Current |
| Deependra Singh | Director | 05 Jan 2021 | 5 Years 10 Months | Current |
Peer comparison
Decan Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Swajan Vanijya Limited | ₹3 Lakh (FY 2016) | Labhpur, West Bengal, India | ||||
| Milaya Media Private Limited | ₹3 Lakh (FY 2018) | New Delhi, Delhi, India | ||||
| R.Akooji Jadwet and Company Private Limited | ₹3 Lakh (FY 2024) | -32.0% | Andaman and Nicobar Islands, India | |||
| Bryan Sales Private Limited | ₹3 Lakh (FY 2018) | -97.0% | Kolkata, West Bengal, India | |||
| Denovo Pharmaceuticals Private Limited | ₹3 Lakh (FY 2021) | -62.0% | Giddarbaha, Punjab, India | |||
| Decan Pharma Private Limitedthis company | ₹3 Lakh (FY 2023) | -₹61,417 | -20.5% | -85.0% | Indore, Madhya Pradesh, India | |
| New Mount Crusher Private Limited | ₹3 Lakh (FY 2025) | -38.0% | Udaipur, Rajasthan, India | |||
| Essense Aromatics Private Limited | ₹3 Lakh (FY 2024) | 3.0% | Lucknow, Uttar Pradesh, India | |||
| Acuman Fincom Private Limited | ₹3 Lakh (FY 2025) | -4.0% | Kolkata, West Bengal, India | |||
| Atom Alloys India Private Limited | ₹3 Lakh (FY 2024) | -41.0% | Panvel, Maharashtra, India | |||
| Oven Commercial Pvt Ltd | ₹3 Lakh (FY 2025) | -31.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Decan Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Decan Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Decan Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Decan Pharma Private Limited has 1 active EPFO establishment as of Nov 13, 2026.
GST
Decan Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAICD2341L1ZS | Madhya Pradesh | Active | 09 Feb 2021 |
To see the full GST registrations and return filing status of Decan Pharma Private Limited, buy the company report.
Recent activity
Decan Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Jaykant Kushwaha ceased to be Director on 26 Mar 2024.
Frequently asked questions
Decan Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in other human health activities, within the healthcare industry. It was incorporated on 05 January 2021 (5+ years old) and is registered under CIN U85190MP2021PTC054382.
Decan Pharma has 2 current directors:
- Hari Shankar Rajawat - Director
- Deependra Singh - Director
The latest financial statements of Decan Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Decan Pharma is 23AAICD2341L1ZS, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Decan Pharma is U85190MP2021PTC054382. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Decan Pharma was incorporated on 05 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Decan Pharma by revenue are Swajan Vanijya Limited, Milaya Media Private Limited, R.Akooji Jadwet and Company Private Limited, Bryan Sales Private Limited, Denovo Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Jaykant Kushwaha ceased to be Director on 26 Mar 2024. Ritesh Kushwah ceased to be Director on 26 Mar 2024. Hari Shankar Rajawat was appointed as Director on 27 Feb 2021. Decan Pharma has 4 board changes on record in total.
The registered office of Decan Pharma is at CO Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006.
Decan Pharma operates in the healthcare industry, in the other human health activities segment.
Decan Pharma can be reached at its registered office: CO Hari Shankar Rajawat Plot No 150 Scheme No 51, Indore, Madhya Pradesh, India – 452006.

